Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CNSP | CNS Pharmaceuticals, Inc. | Chief Executive Officer, Director | $233K | +$50K | +27.4% | Apr 8, 2024 |
MBRX | Moleculin Biotech, Inc. | Director | May 25, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|